Multiple sclerosis patients given PBS lifeline amid drug pricing dispute
Life-changing drugs used to treat multiple sclerosis (MS) will remain subsidised for Australians as Labor pledges to resolve…
FDA approves new kind of cholesterol pill
Merck said on Thursday the Food and Drug Adminstration has approved its cholesterol pill, the first of its…
Medication supply holds steady | The Star
PETALING JAYA: Malaysia’s pharmaceutical supply remains stable despite uncertainty in the Strait of Hormuz, but industry players warn…
Multibillion dollar settlement could mean you pay less for your prescriptions – WSB-TV
Multibillion dollar settlement could mean you pay less for your prescriptions WSB-TVCVS Caremark Reaches FTC Settlement Over Drug Rebates…
Ozempic, Wegovy, Ro: GLP-1 ads are taking over social media
Table of Contents Table of Contents Table of Contents Fighting to stay in recovery GLP-1 content on social…
Opioid Prescribing by Pain Specialists on the Rise
TOPLINE Opioid prescribing by pain medicine specialists rose between 2010 and 2024, while prescribing by primary care physicians…
My Mother Had Alzheimer’s. That’s Why I Started a GLP-1
As an endocrinologist, I spend much of my day discussing GLP-1 medications with my patients. This week, I…
GLP-1 weight-loss drugs may lower the need for knee replacement
The GLP-1 drugs, which include semaglutide (Ozempic, Rybelsus, Wegovy) and tirzepatide (Mounjaro, Zepbound), are turning out…
2.5 million bottles of prescription eye drops recalled
(SACRAMENTO) Lupin Pharmaceuticals has initiated a voluntary recall of more than 2.5 million bottles of prednisolone acetate ophthalmic…
A new pancreatic cancer treatment is hailed as breakthrough, but Canadians don’t have access to it. Here’s why. – CTV News
A new pancreatic cancer treatment is hailed as breakthrough, but Canadians don’t have access to it. Here’s why. CTV…
Repatha Side Effects and How It Compares to Statins
Repatha Side Effects and How It Compares to Statins Use left and right arrow keys to navigate between…
Malaysia is paying too much for medicines; who really benefits?
MALAYSIA spends billions of ringgit each year on medicines for the public healthcare system. Yet a significant share…